UK markets close in 8 hours 8 minutes

GlaxoSmithKline plc (GLAXF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
20.080.00 (0.00%)
At close: 09:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 83.92B
Enterprise value 101.32B
Trailing P/E 15.40
Forward P/E 10.55
PEG ratio (5-yr expected) 1.09
Price/sales (ttm)2.24
Price/book (mrq)4.94
Enterprise value/revenue 2.59
Enterprise value/EBITDA 9.48

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 317.49%
S&P500 52-week change 325.87%
52-week high 323.00
52-week low 316.69
50-day moving average 321.28
200-day moving average 319.64

Share statistics

Avg vol (3-month) 32.35k
Avg vol (10-day) 31.74k
Shares outstanding 54.08B
Implied shares outstanding 64.09B
Float 83.94B
% held by insiders 11.61%
% held by institutions 144.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 43.57%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 32.94%
5-year average dividend yield 44.94
Payout ratio 453.31%
Dividend date 310 Oct 2019
Ex-dividend date 416 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.59%
Operating margin (ttm)30.52%

Management effectiveness

Return on assets (ttm)9.31%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)7.57
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 10.54B
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)1.38
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)5.63B